Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in US Ruchika Sharma7 Oct 2024 12:30 PM ISTHyderabad: NATCO Pharma Limited has announced that its partner Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement of the U.S....
Semaglutide associated with lower opioid overdoses in people OUD and type 2 diabetes: JAMA Dr. Kamal Kant Kohli27 Sept 2024 9:00 AM ISTSince being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the...
JAMA Study finds No link between GLP-1 analogues and suicide Dr. Kamal Kant Kohli5 Sept 2024 9:00 AM ISTThere has been concern that common diabetes drugs could increase the risk of suicide and self-harm. In a new study, led by researchers at Karolinska...
Combining Two Diabetes Drugs Helps Promote Weight Loss and Blood Sugar Control, suggests study Dr. Kamal Kant Kohli2 Sept 2024 7:00 AM ISTNew research finds a combination of drugs improves weight loss, glucose control and insulin resistance better than either drug alone. Using two...
Medical Bulletin 15/ July/ 2024 Anshika Mishra15 July 2024 3:00 PM ISTHere are the top medical news for the day:Ozempic Use Linked to Reduced Dementia Risk, Nicotine Consumption: Study A widely used diabetes medication,...
Ozempic Use Linked to Reduced Dementia Risk, Nicotine Consumption: Study Anshika Mishra15 July 2024 8:00 AM ISTA widely used diabetes medication, Ozempic (semaglutide), may be associated with a reduced risk of cognitive issues, according to an observational...
Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning Ruchika Sharma3 July 2024 6:45 PM ISTThe U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...
Boosting local manufacturing: India plans incentives for diabetes, obesity drug makers in 2026 Ruchika Sharma29 Jun 2024 12:57 PM ISTBengaluru: India is set to provide incentives aimed at boosting domestic production of GLP-1 drugs, which are utilized to manage diabetes and...
WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs Ruchika Sharma22 Jun 2024 4:46 PM ISTGeneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
GLP-1 receptor agonist drugs effective but come with complex concerns shows Research Dr. Kamal Kant Kohli12 Jun 2024 8:45 AM ISTDrugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight...
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
